loadpatents
name:-0.041582107543945
name:-0.032752990722656
name:-0.0054500102996826
Black; Cameron Patent Filings

Black; Cameron

Patent Applications and Registrations

Patent applications and USPTO patent grants for Black; Cameron.The latest application filed is for "substituted 2-morpholinopyridine derivatives as atr kinase inhibitors".

Company Profile
4.31.32
  • Black; Cameron - Baie-D'Urfe CA
  • BLACK; Cameron - St-Laurent CA
  • Black; Cameron - Sacramento CA
  • Black; Cameron - Baic d'Urfe CA
  • Black; Cameron - Burnsville MN
  • Black, Cameron - Quebec CA
  • Black; Cameron - Kirkland CA
  • Black; Cameron - Pointe Claire CA
  • Black; Cameron - Springdale Pointe Claire CA
  • Black; Cameron - Point Claire CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted 2-morpholinopyridine Derivatives As Atr Kinase Inhibitors
App 20220185809 - Crane; Sheldon N. ;   et al.
2022-06-16
Compounds, Pharmaceutical Compositions, And Methods Of Preparing Compounds And Of Their Use As Atr Kinase Inhibitors
App 20210277002 - CRANE; Sheldon N. ;   et al.
2021-09-09
Adjustable light emitting diode luminaire device and system for customized installation
App 20210131620 - Mellor; Jeffry ;   et al.
2021-05-06
Adjustable light emitting diode luminaire device and system for customized installation
Grant 10,883,677 - Mellor , et al. January 5, 2
2021-01-05
Adjustable light emitting diode luminaire device and system for customized installation
App 20200041079 - Mellor; Jeffry ;   et al.
2020-02-06
Adjustable light emitting diodge luminaire device and system for customized installation
Grant 10,495,272 - Mellor , et al. De
2019-12-03
Adjustable light emitting diodge luminaire device and system for customized installation
App 20190024856 - Mellor; Jeffry ;   et al.
2019-01-24
TC-PTP inhibitors as APC activators for immunotherapy
Grant 10,150,787 - Tremblay , et al. Dec
2018-12-11
Tc-ptp Inhibitors As Apc Activators For Immunotherapy
App 20180265531 - TREMBLAY; Michel L. ;   et al.
2018-09-20
TC-PTP inhibitors as APC activators for immunotherapy
Grant 10,005,804 - Tremblay , et al. June 26, 2
2018-06-26
Tc-ptp Inhibitors As Apc Activators For Immunotherapy
App 20180072763 - TREMBLAY; Michel L. ;   et al.
2018-03-15
Adjustable light emitting diode luminaire device and system for customized installation
App 20170350564 - Mellor; Jeffry ;   et al.
2017-12-07
TC-PTP inhibitors as APC activators for immunotherapy
Grant 9,828,399 - Tremblay , et al. November 28, 2
2017-11-28
Tc-ptp Inhibitors As Apc Activators For Immunotherapy
App 20170015690 - TREMBLAY; Michel L. ;   et al.
2017-01-19
Composition For Inhibition Of Cathepsin K
App 20150250759 - Daifotis; Anastasia ;   et al.
2015-09-10
Cathepsin Cysteine Protease Inhibitors
App 20140256743 - Bayly; Christopher I. ;   et al.
2014-09-11
Cathepsin cysteine protease inhibitors
Grant 8,772,336 - Bayly , et al. July 8, 2
2014-07-08
Composition For Inhibition Of Cathepsin K
App 20140186471 - Daifotis; Anastasia ;   et al.
2014-07-03
Composition for inhibition of cathepsin K
Grant 8,722,734 - Daifotis , et al. May 13, 2
2014-05-13
Cathepsin Cysteine Protease Inhibiors
App 20130035312 - Bayly; Christopher I. ;   et al.
2013-02-07
Cathepsin cysteine protease inhibitors
Grant 8,318,748 - Bayly , et al. November 27, 2
2012-11-27
Cathepsin Cysteine Protease Inhibitors For The Treatment Of Various Diseases
App 20120101053 - Black; Cameron ;   et al.
2012-04-26
Cathepsin Cysteine Protease Inhibitors
App 20110230446 - Bayly; Christopher I. ;   et al.
2011-09-22
Cathepsin cysteine protease inhibitors
Grant 7,973,037 - Bayly , et al. July 5, 2
2011-07-05
Cathepsin cysteine protease inhibitors
Grant 7,928,091 - Black , et al. April 19, 2
2011-04-19
Papain Family Cysteine Protease Inhibitors for the Treatment of Parasitic Diseases
App 20090264479 - Black; Cameron ;   et al.
2009-10-22
Cathepsin cysteine protease inhibitors
App 20090176859 - Bayly; Christopher ;   et al.
2009-07-09
Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 Desaturase
App 20090118296 - Black; Cameron ;   et al.
2009-05-07
Fluoroalkylamine Derivatives as Cathepsin Inhibtors
App 20090099264 - Black; Cameron ;   et al.
2009-04-16
Cathepsin Cysteine Protease Inhibitors
App 20090093444 - Black; Cameron ;   et al.
2009-04-09
Composition for Inhibition of Cathepsin K
App 20080255072 - Daifotis; Anastasia ;   et al.
2008-10-16
Cathepsin cysteine protease inhibitors
App 20080188529 - Bayly; Christopher I. ;   et al.
2008-08-07
Cathepsin cysteine protease inhibitors
Grant 7,405,229 - Bayly , et al. July 29, 2
2008-07-29
Cathepsin cysteine protease inhibitors
Grant 7,375,134 - Bayly , et al. May 20, 2
2008-05-20
Cyanoalkylamino derivatives as protease inhibitors
Grant 7,371,747 - Black , et al. May 13, 2
2008-05-13
Cathepsin cysteine protease inhibitors
App 20070167635 - Bayly; Christopher ;   et al.
2007-07-19
Cathepsin inhibitors
App 20060287402 - Bayly; Christopher ;   et al.
2006-12-21
System and method for data management
Grant 7,103,602 - Black , et al. September 5, 2
2006-09-05
4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis
App 20060166966 - Black; Cameron
2006-07-27
Cathepsin cysteine protease inhibitors
App 20050240023 - Bayly, Christopher I. ;   et al.
2005-10-27
System and method for data management
App 20050203864 - Schmidt, Ross A. ;   et al.
2005-09-15
Cyanoalkylamino derivatives as protease inhibitors
App 20050014941 - Black, Cameron ;   et al.
2005-01-20
Cathepsin cysteine protease inhibitors
App 20030232863 - Bayly, Christopher I. ;   et al.
2003-12-18
Gamma-ketoacid dipeptides as inhibitors of caspase-3
Grant 6,525,025 - Han , et al. February 25, 2
2003-02-25
System and method for data management
App 20030004922 - Schmidt, Ross A. ;   et al.
2003-01-02
Gamma-ketoacid dipeptides as inhibitors of caspase-3
App 20020165230 - Han, Yongxin ;   et al.
2002-11-07
System and method for data management
App 20020059317 - Black, Cameron ;   et al.
2002-05-16
Diaryl-2-(5H)-furanones as Cox-2 inhibitors
Grant 6,222,048 - Black , et al. April 24, 2
2001-04-24
3,4-Diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
Grant 6,057,319 - Black , et al. May 2, 2
2000-05-02
(Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
Grant 6,020,343 - Belley , et al. February 1, 2
2000-02-01
Bisaryl COX-2 inhibiting compounds, compositions and methods of use
Grant 5,994,379 - Bayly , et al. November 30, 1
1999-11-30
(Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
Grant 5,981,576 - Belley , et al. November 9, 1
1999-11-09
Alkylated styrenes as prodrugs to COX-2 inhibitors
Grant 5,925,631 - Black , et al. July 20, 1
1999-07-20
Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
Grant 5,922,742 - Black , et al. July 13, 1
1999-07-13
Alkylated styrenes as prodrugs to COX-2 inhibitors
Grant 5,789,413 - Black , et al. August 4, 1
1998-08-04
Diphenyl stilbenes as prodrugs to COX-2 inhibitors
Grant 5,733,909 - Black , et al. March 31, 1
1998-03-31
3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhibitors
Grant 5,698,584 - Black , et al. December 16, 1
1997-12-16
Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
Grant 5,691,374 - Black , et al. November 25, 1
1997-11-25
N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
Grant 5,639,780 - Lau , et al. June 17, 1
1997-06-17
N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
Grant 5,604,253 - Lau , et al. February 18, 1
1997-02-18
N-benzyl-3-indoleacetic acids as antiinflammatory drugs
Grant 5,510,368 - Lau , et al. April 23, 1
1996-04-23
1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
Grant 5,436,265 - Black , et al. July 25, 1
1995-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed